Metropolis Healthcare Limited IPO

Add to Calendar 2019-04-03 12:00 AM 2019-04-05 12:00 AM Asia/Kolkata Metropolis Healthcare Limited IPO Metropolis Healthcare Limited India

Metropolis Healthcare Limited is a leading diagnostics company in India by revenue that offers an inclusive range of clinical laboratory tests and profiles (Source: Frost & Sullivan). It offers a wide range of 3,480 clinical laboratory tests and 524 profiles that are classified across “routine”, “semi-specialized” and “specialized” tests. As on 31st March 2018, the company have 4,585 employees on its payroll.

Date of Incorporation: The Company was initially incorporated as “Dr V. K. Desai Hospital” as a partnership firm in January 1980. Subsequently, it was amended to “Metropolis Healthcare Limited” beginning as a public limited company on 23rd September 2009.

Promoters of the Company: Dr Sushil Kanubhai Shah, Ameera Sushil Shah and Metz Advisory LLP are the promoters of Metropolis Healthcare Limited.

Products and Services: It offers a range of clinical tests and profiling that are used for prediction, early detection, diagnostic screening, confirmation and monitoring of disease. It caters the customer through:

  • - Individual patients are served through Patient touch points, home collection service.

  • - Healthcare providers are served through pick-up points and ARC’s.

  • - Other Customers are served through clinical research, PPP and Laboratory in Hospital.

Customer Segments: Metropolis Healthcare Limited has its ARCs, clinical laboratories and patient touch points across India in states of Maharashtra, Gujarat, Andhra Pradesh, Rajasthan, Karnataka, Delhi, Bihar, West Bengal and several other states.

While it has also active presence outside India across Ghana, Kenya, Zambia, Mauritius and Sri Lanka. It has also ventured with third parties in Nepal, Nigeria, UAE and Oman.

Objects of the Offer: The main objectives of Metropolis Healthcare Limited are:

  • - Finance offer related to expenses.

  • - Monitoring Utilization of Funds.

  • - Offer for Sale by selling stakeholders.

Company Financials:


For the year/period ended (in Rs. Millions)




Total Assets




Total Revenue




Profit After Tax




Issue Detail

  • Issue Open: Apr 03, 2019
  • Issue Close: Apr 05, 2019
  • Issue Type: Book Built Issue
  • Face Value: Rs 2 Per Equity Share
  • Price Band: Rs 877 - Rs 880 Per Equity Share
  • Bid Lot:17 Shares
  • Minimum Order Quantity:17 Shares
  • Listing At: BSE, NSE
  • Issue Size: • Rs 1,339.15 Cr

Current Bidding Status

Number of Times Subscribed (BSE + NSE)
As on Date & Time QIB NII RII Employee Others Total
Shares Offered / Reserved 4,015,529 2,007,764 1,338,509 300,000 - 7,661,802
Day 1 - Apr 03, 2019IST 0.09x 0.00x 0.25x 0.00x - 0.09x
Day 2 - Apr 04, 2019IST 0.65x 0.02x 0.70x 0.01x - 0.47x
Day 3 - Apr 05, 2019IST 8.88x 3.03x 2.02x 0.05x - 5.80x

Listing Day Trading Information

Issue Price - -
Open - -
Low - -
High - -
Last Trade - -
Volume - -

Metropolis Healthcare Limited Red Herring Prospectus

Metropolis Healthcare Limited User Rating


Metropolis Healthcare Limited Life IPO Reviews

Metropolis Healthcare Limited IPO News & Updates

Frequently Asked Questions

Yes, you can always trade an IPO through a discount broker. Buying & selling an IPO becomes very easy once the trading and the demat account are set up appropriately.
Following are the benefits in buying and selling an IPOs through a discount broker. Reduced Brokerage Fee: Discount brokers charge a flat brokerage which is missing in case of full service brokers. Full service brokers usually charge %age brokerage and this incurs a lot of cost to an investors. So if any full service broker charge a brokerage of let say 0.03% then on a purchase of shares of worth of Rs 200,000 you end up paying Rs 600+ Taxes. In our case we charge a flat brokerage of Rs 20 + Taxes. Discount brokers therefore saves a lot of money of investors. Better Trading Platform: Usually discounts brokers don’t provide a good trading platform and experience but there are few discounts brokers like Samco, who are now focussing on delivering a world class trading platform and top notch user experience. Therefore narrowing down the gap between discount brokers and full service brokers.
Technically Speaking, SEBI has made mandatory to buy an IPO through ASBA channel but there is no regulation on how any investor can sell an IPO allotted shares. Therefore, smart investors can always sell IPO allotted shares through a discount broker


Start IPO Trading through SAMCO

Don't have a Trading Account !!!
Open an account with Samco and Do IPO Trading for Just Rs 20. For more details, share your contact details with us